MedPath

Remote Monitoring System for Patients, Who Had Myocardial Infarction

Not Applicable
Conditions
Myocardial Infarction
Adherence, Patient
Interventions
Device: The remote monitoring system
Registration Number
NCT04424368
Lead Sponsor
Ryazan State Medical University
Brief Summary

one-centered, open, prospective, non-randomized, controlled clinical study will be aimed at creating remote monitoring system for patients' condition and the development of methodological approaches and its usage for conducting patients, who had myocardial infraction and who has a very high risk of developing an unfavorable outcome.

Detailed Description

The research will involve patients, who had myocardial infraction and who has the high level of potential adherence to treatment, which will be determined by the usage of Russian generic questionnaire for evaluation of compliance to drug therapy. At the end of a 12 month observation with the registration of unfavorable cardiovascular occasions (death from cardiovascular reasons, nonfatal myocardial infraction, cerebral stroke, necessity for repeated revascularization of the coronary arteries) based on the analysis of non-genetic and genetic factors (polymorphism of genes Thr174Met and Met235Thr in gene angiotensinogen, Arg389Gly and Ser49Gly in gene adrenoceptor beta 1, Ser447Ter in gene lipoprotein lipase and Leu28Pro in gene apolipoprotein E, Trp212Ter and G681A in gene cytochrome P450 family 2 subfamily C member 19) factors of unfavorable prognosis will be identified and considering which group of patients requires the use of remote monitoring system will be formed. From one group of patients we will form two comparable groups, one group will use this remote monitoring system and another will not. The effectiveness of the remote monitoring system will be evaluated after 6-month's observation based on the registration of the unfavorable cardiovascular occasions (death from cardiovascular reasons, nonfatal myocardial infraction, cerebral stroke, necessity for repeated revascularization of the coronary arteries, frequency of hospitalizations).

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
250
Inclusion Criteria
  1. A significant diagnosis of myocardial infraction, confirmed by the level of biomarkers of myocardial necrosis in blood examination (troponin, creatine kinase-MV), electrocardiographic criteria, typical clinical presentation.
  2. The high level of adherence to treatment
  3. Signed informed agreement
Exclusion Criteria
  1. Active cancer or remission period less than 5 years;
  2. Absolute contradictions to the prescription of beta-adrenergic blocking agents, angiotensin converting enzyme inhibitors, statins, antiaggregants.
  3. Mental illnesses.
  4. Alcohol and drug abuse
  5. Patient's noncompliance, according to the researchers

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
The remote monitoring systemThe remote monitoring systemA group of patients, who had myocardial infraction and who has a very high risk of developing an unfavorable prognosis, which are followed up in the local outpatient department according to existing clinical recommendations and using remote monitoring system.
Primary Outcome Measures
NameTimeMethod
hospitalization12 months

frequency of hospitalization about the progression of coronary heart disease

cardiovascular mortality12 months

the number of deaths from cardiovascular causes

acute myocardial infarction12 months

incidence of acute myocardial infarction

cerebral stroke12 months

incidence of cerebral stroke

revascularization12 months

frequency of repeated revascularization of coronary arteries

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

RyazSMU

🇷🇺

Ryazan', Russian Federation

© Copyright 2025. All Rights Reserved by MedPath